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Intravenous access cannot always be promptly obtained when treating status epilepticus outside the hospital. We compared
the efficacy and safety of diazepam rectal gel to IV lorazepam in our long-term care facility for adults with developmental
disabilities. Diazepam rectal gel was given more quickly and reliably, reducing total seizure time, potential neuronal injury and
other complications. A treatment protocol for treating status epilepticus with diazepam rectal gel is given.
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INTRODUCTION
Convulsive status epilepticus, especially the gener-
alised type, is an emergency with risk of substantial
morbidity and mortality. Its treatment should focus
on an operational definition with the primary goal of
prompt cessation of seizures. Early treatment reduces
total seizure time and improves medication response,
and may decrease potential neuronal injury and other
complications1, 2. Many emergency rooms and hospi-
tals have standard protocols, usually involving IV lo-
razepam.
When status epilepticus occurs outside the hospital
or when IV access is not possible, alternative routes
for drug administration must be used3. At Fircrest it
has been very difficult to reliably and quickly obtain
IV access in our residents because of muscular con-
tractures and atrophy, seizure movements and obesity.
A protocol is followed at Fircrest to eliminate treat-
ment delay and to avoid excessive use of emergency
paramedic ambulance service.
Rectal diazepam is an effective and safe treatment
for prolonged seizures outside the hospital4, 5. It
achieves blood levels adequate for seizure treatment
more rapidly than any route except for the IV one6.
Diazepam is absorbed more quickly by the rectal route
than lorazepam because it is more lipid soluble. Rec-
tal diazepam solution was not used widely at Fircrest
because it tended to leak out of the rectum, leading to
inaccurate dosing and treatment failure. In 1997, di-
azepam became available as a rectal gel formulation
contained in a pre-filled, rectal syringe (Diastat®)
that provides easy and rapid administration. It has
rapid, consistent absorption7. In placebo-controlled
studies, it has been proven safe and effective in treat-
ing out-of-hospital acute repetitive seizures8, 9. It has
FDA approval for acute repetitive seizures but not
for status epilepticus10. Anecdotal reports mention
its successful use in status epilepticus. These cases
involve rural settings and ER patients with difficult
IV access. There is a lack of systematic studies on its
efficacy and safety in status epilepticus, especially in
adults.
Buccal midazolam11, 12 and intranasal midazo-
lam13–15 are other potential treatment options. These
novel seizure treatments are not as well studied as
rectal diazepam and require further investigation to
document their efficacy, proper dosing and safety.
METHOD
Fircrest is a state-operated long-term care facil-
ity housing 300 severely developmentally disabled
adults, many of whom have medically intractable
epilepsy. It provides a highly structured environment
1059–1311/02/120052 + 04 $35.00/0 © 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
Treatment of out-of-hospital status epilepticus 53
with 24-hour nursing care and staff physicians. Wit-
nessed seizures are routinely documented on our
designated seizure sticker form and placed in the
patient’s chart. The seizure sticker contains the fol-
lowing: date, time of start and end of seizure, seizure
characteristics checklist (twitch, jerk, upper body,
whole body, bit tongue, blue face, loss of conscious-
ness and wet pants) and signature. Nurses routinely
document medication administration time and other
patient information in the chart.
Nurses initiated a treatment attempt for status
epilepticus after 10 minutes of continuous generalised
tonic-clonic seizure activity. From 1st May 1996 to
30th April 1998 this treatment consisted of 4 mg of
IV lorazepam; from 1st May 1998 to 1st May 1999,
for the same individuals, it consisted of 15–20 mg of
diazepam rectal gel. The following data were retro-
spectively reviewed: time of administration, time to
cessation of seizure, time of total seizure and adverse
drug reactions. This study was approved by Fircrest’s
Human Rights Committee.
Table 1: Intravenous lorazepam results.
Patient Time (minute)a Treatments Dose (mg; mg kg−1 dosage)
To administer To stop seizure Total seizure
1 16 ± 5 5 ± 2 22 ± 3 5 4 (0.11)
2 20 ± 6 4 ± 2 24 ± 6 5 4 (0.06)
3 21 ± 9 4 ± 3 25 ± 12 2 4 (0.09)
4 32 ± 17 5 ± 0 37 ± 17 2 4 (0.1)
5 30 ± 6 6 ± 3 37 ± 10 2 4 (0.09)
6 15 ± 3 3 ± 0 18 ± 3 5 4 (0.06)
Total 20 ± 3 4 ± 1 25 ± 3 21 4 (0.08 ± 0.01)
a Time to administer from start of seizure and to stop from administration.
Table 2: Diazepam rectal gel results.
Patient Time (minute) Treatments Dose (mg; mg kg−1 dosage)
To administer To stop seizure Total seizure
1 12 ± 2 6 ± 1 18 ± 2 8 15 (0.42)
2 11 ± 4 7 ± 1 19 ± 4 5 20 (0.33)
3 17 ± 4 8 ± 3 26 ± 6 6 15 (0.33)
4 12 ± 2 3 ± 0.5 15 ± 2 2 15 (0.37)
5 10 ± 1 6 ± 1 16 ± 2 5 15 (0.34)
6 8 ± 1 7 ± 1 16 ± 2 10 20 (0.31)
Total 12 ± 1 7 ± 1 18 ± 1 36 17 (0.35 ± 0.02)
Table 3: Comparison of treatments: rectal diazepam gel and IV lorazepam.
Treatment Successful admin-
istration (%)
Mean time (minute) Responders within 10
minutes (%)To administer To stop seizure Total seizure
Diazepam gel 100 12 ± 1* 7 ± 1** 18 ± 1* 83
IV Lorazepam 30 20 ± 3* 4 ± 1** 25 ± 3* 95
* P < 0.05, paired t test; ** P > 0.05, paired t test.
All individuals with at least one treatment attempt
of both diazepam and lorazepam were included in our
study population. Paired t test was done to statistically
analyse how the same patients responded to the two
treatments. Of the six patients in our study popula-
tion, five were female. The average patient age was 29
(range 20–39 years). The average patient body weight
was 48 (range 36–64 kg). Five were white and one
was Native American in race.
RESULTS
The outcome of 107 total treatment attempts is
summarised in Tables 1–3. Data included multiple
treatment attempts of both medications for each indi-
vidual. This shows that diazepam was administered in
all 36 attempts whereas lorazepam in 21 out of 71 at-
tempts (30%). The time to administration of diazepam
was significantly shorter than lorazepam. There was
a significant reduction (27%) of total seizure time
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for diazepam compared to lorazepam. After a single
dose of either medication, 83% of patients responded
within 10 minutes after diazepam whereas 95% after
lorazepam. Within 20 minutes all patients responded.
In the diazepam treatment attempts, four seizures
(11%) were longer than 30 minutes whereas in the
lorazepam attempts 20 seizures (28%) exceeded
30 minutes. One episode of transient hypotension
resolved without sequelae for both treatments. No
respiratory difficulties were reported.
DISCUSSION
A key finding was that diazepam rectal gel was ac-
tually administered in all 36 attempts whereas IV lo-
razepam was administered in only 21 of 71 attempts
(30%). This clearly shows how difficult it is to give
IV lorazepam in these patients. In addition, even when
IV lorazepam was actually given, the average time
to administration was 20 minutes whereas diazepam
rectal gel was given significantly faster (P < 0.002)
at an average of 12 minutes into seizure. This is the
basis for the superior response to rectal diazepam
treatment.
When either medication was actually given, seizures
stopped quickly without significant difference (P <
0.063), in an average of 4 minutes for lorazepam and
7 minutes for diazepam. Lorazepam worked faster
but not enough to compensate for the long treat-
ment delay due to difficulties of IV administration.
Also, when medication was actually given, average
total seizure time proved to be significantly shorter
(P < 0.026) after diazepam (18 minutes) than after
lorazepam (25 minutes).
Regarding treatment attempts in which medication
was not necessarily given, we found that in the di-
azepam attempts, four seizures (11%) lasted longer
than 30 minutes whereas in the lorazepam attempts,
20 seizures (28%) exceeded 30 minutes. This is im-
portant because when a patient seizes for more than
30 minutes at our facility, it is likely that we will call
the emergency paramedic ambulance service to trans-
fer the patient out to an emergency room.
Two factors may have contributed to the success of
diazepam rectal gel. First, it was given reliably and
quickly. Second, the average body weight of our pa-
tients was low (48 kg), leading to a higher relative
dosage (0.3 mg kg−1).
A limitation of our study is the small number of pa-
tients. Further study is needed involving a larger num-
ber of individuals in a prospective fashion. Since our
results indicate the unsuitability of IV treatment for
most of our patients, other routes of benzodiazepine
administration, such as buccal and intranasal midazo-
lam, require further investigation.
As a result of our findings, we currently implement
a diazepam rectal gel protocol for status epilepticus at
our facility. This incorporates the current recommen-
dation to initiate treatment after 5 minutes1. During a
seizure the emergency paramedic ambulance service
may be called at any time if the seizure is extremely
severe. Respiratory rate and blood pressure are mon-
itored during and after the seizure. Pulse oximeter,
oxygen, bag-valve mask ventilator and emergency
medications are available if needed. Our protocol is
initiated after a generalised tonic-clonic seizure last-
ing at least 5 minutes or two generalised tonic-clonic
seizures within 1 hour between which there is in-
complete recovery of consciousness. The first step is
administration of 20 mg (15 mg for patients <40 kg)
and an IV line is attempted. The second step is an ad-
ditional 10 mg if the seizure continues for 10 minutes
after the initial dose. If possible give 4 mg of IV lo-
razepam instead. The physician is notified. The third
step is to call the emergency paramedic ambulance
service if the seizure continues for 10 minutes after
the second dose.
CONCLUSIONS
In this patient population, diazepam rectal gel typi-
cally can be administered more quickly and reliably
than IV lorazepam, reducing seizure duration, poten-
tial neuronal injury and other potential complications.
It is an appropriate and effective treatment for status
epilepticus in this setting.
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